Try our Advanced Search for more refined results
October 29, 2010
Track this case
Judge Tanya Walton Pratt
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.Additional or older documents may be available in Pacer.
An Indiana federal judge on Tuesday ruled that Teva Parenteral Medicines Inc.’s proposed labeling for a generic version of the cancer drug Alimta would cause physicians to infringe Eli Lilly & Co.’s vitamin-regimen patent.
Already a subscriber? Click here to login